Literature DB >> 7999068

Mapping of two phenol sulphotransferase genes, STP and STM, to 16p: candidate genes for Batten disease.

T P Dooley1, H M Mitchison, P B Munroe, P Probst, M Neal, M J Siciliano, Z Deng, N A Doggett, D F Callen, R M Gardiner.   

Abstract

The cytosolic phenol sulphotransferase gene (STP) was mapped to a region of chromosome 16, within the interval defined by human-rodent somatic cell hybrid breakpoints CY160(D) and CY12, which contains FRA16E. YAC and cosmid clones from this 16p interval were screened for the presence of STP. Two non-overlapping cosmid contigs were identified which contain STP-like sequences. Sequencing of these STP-like sequences confirmed that STP is contained within contig 343.1 and maps proximal to FRA16E, and that a related sulphotransferase STM, encoding the catecholamine-sulphating enzyme, is contained within contig 55.4 and maps to the adjacent hybrid interval CY12-CY180A. Thus two phenol sulphotransferase genes (STP and STM) have been finely localised to chromosome 16p12.1-p11.2, to the same region as CLN3, the gene for Batten disease. Both genes are therefore candidate genes for Batten disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7999068     DOI: 10.1006/bbrc.1994.2691

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Fragility Extraordinaire: Unsolved Mysteries of Chromosome Fragile Sites.

Authors:  Wenyi Feng; Arijita Chakraborty
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 2.  Pharmacogenetics of soluble sulfotransferases (SULTs).

Authors:  Hansruedi Glatt; Walter Meinl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-05       Impact factor: 3.000

Review 3.  Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation.

Authors:  B Burchell; M W Coughtrie
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

Review 4.  Are common fragile sites merely structural domains or highly organized "functional" units susceptible to oncogenic stress?

Authors:  Alexandros G Georgakilas; Petros Tsantoulis; Athanassios Kotsinas; Ioannis Michalopoulos; Paul Townsend; Vassilis G Gorgoulis
Journal:  Cell Mol Life Sci       Date:  2014-09-20       Impact factor: 9.261

5.  Human Sulfotransferase Assays With PAPS Production in situ.

Authors:  Yanan Sun; Lukas Corbinian Harps; Matthias Bureik; Maria Kristina Parr
Journal:  Front Mol Biosci       Date:  2022-02-28

6.  Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-users.

Authors:  Merete Ellingjord-Dale; Eunjung Lee; Elisabeth Couto; Ali Ozhand; Samera Qureshi; Solveig Hofvind; David J Van Den Berg; Lars A Akslen; Tom Grotmol; Giske Ursin
Journal:  Breast Cancer Res       Date:  2012-10-27       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.